Kampanjeplan Esperion Therapeutics, Inc.
Avansert tidsplan
Enkel graf
Om selskapet
Фармацевтическая компания Esperion Therapeutics, Inc. разрабатывает и продает лекарства для лечения пациентов с повышенным уровнем холестерина липопротеинов низкой плотности в США и за рубежом. Его основными кандидатами в продукты являются таблетки NEXLETOL (бемпедоевая кислота) и NEXLIZET (бемпедоевая кислота и эзетимиб) для лечения пациентов с атеросклеротическим сердечно-сосудистым заболеванием или гетерозиготной семейной гиперхолестеринемией.
Flere detaljer| Сайт | https://www.esperion.com |
|---|---|
| P/S | 10.96 |
| P/BV | 81.5 |
| EV/EBITDA | -16.41 |
| EBITDA | -0.089 |
| Число акций ао | 0.10311 млрд |
| Цена ао | 2.13 |
| Выручка | 0.1484 |
| Див.доход ао | 0 |
| ISIN | US29664W1053 |
| Валюта | usd |
| IPO date | 2013-06-26 |
| Sector | Health Care |
| Industry | Biotechnology |
| Валюта отчета | usd |
| Prisendring per dag: | +8.12% (1.97) |
|---|---|
| Prisendring per uke: | +2.9% (2.07) |
| Prisendring per måned: | +11.52% (1.91) |
| Prisendring over 3 måneder: | -18.7% (2.62) |
| Prisendring over seks måneder: | +13.9% (1.87) |
| Prisendring per år: | +126.6% (0.94) |
| Prisendring over 3 år: | -57.4% (5) |
| Prisendring over 5 år: | -93.76% (34.16) |
| Prisendring over 10 år: | -96.77% (65.98) |
| Prisendring siden begynnelsen av året: | +78.99% (1.19) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Orbimed Advisors LLC. | 14 | 7.24 |
| Bellevue Group AG | 10 | 5.25 |
| Wasatch Advisors LP | 9 | 4.82 |
| Vanguard Group Inc | 9 | 4.66 |
| Great Point Partners LLC | 8 | 4.22 |
| Woodline Partners LP | 8 | 4.18 |
| Millennium Management LLC | 6 | 3 |
| Shaw D.E. & Co., Inc. | 5 | 2.71 |
| Bank of America Corporation | 5 | 2.4 |
| Two Seas Capital LP | 4 | 2.2 |
| ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
|---|---|---|---|
| Avantis U.S. Equity ETF | 0.00054 | 30.365392144069 | 1.59151 |
| Virtus LifeSci Biotech Products ETF | 0.87132 | 36.788704846892 | 0.13953 |
| ProShares UltraShort Nasdaq Biotechnology | 0.19 | -40.363937138131 | 1.76 |
| Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.02335 | 31.359936575053 | 1.41955 |
| ProShares Hedge Replication ETF | 0.002 | 5.9237999659878 | 1.47892 |
| iShares Micro-Cap ETF | 0.08058 | 34.327031588619 | 1.54048 |
| iShares Russell 2000 Growth ETF | 0.0064 | 38.042556988 | 0.6026 |
| iShares Russell 3000 ETF | 0.00073 | 31.230028873917 | 1.43482 |
| Jacob Forward ETF | 3.54096 | 43.033162930921 | 0.15284 |
| ProShares UltraPro Russell2000 | 0.00686 | 89.821266282945 | 1.47873 |
| Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 37.361289927043 | 0.60264 |
| Vanguard Russell 2000 ETF | 0.01 | 32.773459189339 | 1.48801 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Sheldon L. Koenig | President, CEO & Director | 1.2M | 1966 (58 år) |
| Mr. Eric J. Warren R.Ph. | Chief Commercial Officer | N/A | 1972 (52 år) |
| Ms. Betty Jean Swartz | Chief Business Officer | N/A | |
| Mr. Benjamin Halladay M.B.A. | Chief Financial Officer | N/A | 1986 (38 år) |
| Mr. Glenn P. Brame | Chief Technical Operations Officer | N/A | 1958 (66 år) |
| Tiffany Aldrich M.B.A. | Associate Director of Corporate Communications | N/A | |
| Mr. Benjamin O. Looker J.D. | General Counsel & Corporate Secretary | 1982 (42 år) |
Adresse: United States, Ann Arbor, MI , 3891 Ranchero Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.esperion.com
Nettsted: https://www.esperion.com
